Literature DB >> 2006653

Treatment of hypertension in the elderly: effects on blood pressure, heart rate, and physical fitness.

G Leonetti1, C Mazzola, C Pasotti, L Angioni, A Vaccarella, A Capra, G Botta, A Zanchetti.   

Abstract

The subjects were 36 hypertensive patients aged 61 to 79 years (mean, 66 years). After a placebo run-in period of one month, each patient was randomly assigned to two months of treatment with 100 mg of metoprolol, 50 mg of captopril, or 25 mg of hydrochlorothiazide plus 2.5 mg of amiloride daily, or placebo. The doses were doubled if diastolic pressure was above 95 mm Hg after one month of treatment. Blood pressure, heart rate, and physical fitness (endurance during a standard cycle ergometer exercise) were measured and side effects assessed after each two-month treatment period. Mean blood pressures were significantly lower after treatment with metoprolol (154/92 mm Hg), captopril (157/92 mm Hg), and hydrochlorothiazide-amiloride (152/91 mm Hg) than after placebo (170/101 mm Hg). Heart rate was significantly lower after treatment with metoprolol (64 beats/minute) than after placebo (77 beats/minute). Exercise endurance was lower after treatment with metoprolol (498 seconds) and hydrochlorothiazide-amiloride (519 seconds) than after placebo (529 seconds) and higher after captopril (541 seconds). More patients reached the target exercise work load after captopril than after the other treatments. No patients withdrew from treatment because of side effects or abnormal laboratory test results. All three active treatments benefited the elderly hypertensive patients and did not lower their physical fitness. Captopril appeared to be more effective than the other two treatments.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2006653     DOI: 10.1016/0002-9343(91)90429-2

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  5 in total

1.  Angiotensin-converting enzyme inhibitor and statin use and incident mobility limitation in community-dwelling older adults: the Health, Aging and Body Composition study.

Authors:  Shelly L Gray; Robert M Boudreau; Anne B Newman; Stephanie A Studenski; Ronald I Shorr; Douglas C Bauer; Eleanor M Simonsick; Joseph T Hanlon
Journal:  J Am Geriatr Soc       Date:  2011-11-04       Impact factor: 5.562

Review 2.  Optimal management of sarcopenia.

Authors:  Louise A Burton; Deepa Sumukadas
Journal:  Clin Interv Aging       Date:  2010-09-07       Impact factor: 4.458

Review 3.  Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension.

Authors:  Balraj S Heran; Michelle My Wong; Inderjit K Heran; James M Wright
Journal:  Cochrane Database Syst Rev       Date:  2008-10-08

4.  Novel intriguing strategies attenuating to sarcopenia.

Authors:  Kunihiro Sakuma; Akihiko Yamaguchi
Journal:  J Aging Res       Date:  2012-02-20

5.  Do ACE inhibitors improve the response to exercise training in functionally impaired older adults? A randomized controlled trial.

Authors:  Deepa Sumukadas; Margaret Band; Suzanne Miller; Vera Cvoro; Miles Witham; Allan Struthers; Alex McConnachie; Suzanne M Lloyd; Marion McMurdo
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-11-07       Impact factor: 6.053

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.